INS webinars deliver the most current infusion-related topics in a 60-minute presenter-led session. Each webinar is delivered live and then archived for on-demand viewing.

Webinars

  • Infusion Therapy in Alternative Care Settings

    Contains 3 Component(s), 1.00 credit offered Includes a Live Event on 12/12/2018 at 1:00 PM (EST)

    Administering infusion therapy in alternative care settings requires expert planning and management. Infusion nurses must be knowledgeable when providing care for patients in home, hospice, and other non-acute facilities. This webinar will address best practices for attaining and maintaining vascular access, administration of infusion therapy, and safety and infection control in alternative care settings. 

    Learning Outcomes:
    At the conclusion of this webinar, attendees will:
    a) be able to describe best practices for attaining and maintaining vascular access in alternate care settings and 
    b) identify safety and infection control practices for alternative care settings. 

    Administering infusion therapy in alternative care settings requires expert planning and management. Infusion nurses must be knowledgeable when providing care for patients in home, hospice, and other non-acute facilities. This webinar will address best practices for attaining and maintaining vascular access, administration of infusion therapy, and safety and infection control in alternative care settings. 

    Learning Outcomes:
    At the conclusion of this webinar, attendees will:
    a) be able to describe best practices for attaining and maintaining vascular access in alternate care settings and 
    b) identify safety and infection control practices for alternative care settings. 

    Jan Elliott, BS, RN, CRNI®, VA-BC

    Infusion Therapy and Vascular Access Specialist

    Jan Elliott, BS, RN, CRNI®, VA-BC, is an infusion therapy and vascular access specialist, and the primary hospice and palliative care on-call nurse for Upstate Homecare in Central New York. Throughout her 24-year career, Jan has administered infusion therapy, developed vascular access teams, and provided education for clinicians on pain management in the home, alternative, and acute care settings. She has also worked for various US medical device companies as a clinical specialist, preceptor, and educator. In those roles, Jan helped implement conversions on new technologies, products, and services with a focus on promoting and ensuring safer, effective, and efficient delivery of patient care. Jan has been president of the Association of Vascular Access of Central New York for the past 10 years, and has hosted a teaching day symposium for all health care disciplines with discussions on best practices, innovations, and evidence-based medicine. 

    Disclosure: No conflict of interest to disclose

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: December 12, 2021

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • CAR T-Cells: Treatment Overview, Toxicity Management, and Administration Considerations

    Contains 3 Component(s), 1.00 credit offered Recorded On: 11/14/2018

    Chimeric antigen receptor (CAR) T-cells are cellular immunotherapies used for the treatment of some malignancies. This adoptive cell therapy represents a new paradigm in cancer treatment, one in which the patient’s own immune system, specifically T-cells, are engineered to treat his or her cancer. CAR T-cell therapy is a complex treatment associated with unique and serious toxicities, making education a necessity for both the patient and the health care provider. This presentation will provide an overview of CAR T-cell therapy, toxicity assessment and management strategies, administration considerations, and patient education needs for the health care provider.  

    Learning Outcomes: At the conclusion of this presentation, learners will be able to:
    • Describe the mechanism of action for CAR T-cells
    • Identify 3 common toxicities associated with CAR T-cells, as well as associated management strategies 
    • Verbalize administration considerations for CAR T-cell products

    Chimeric antigen receptor (CAR) T-cells are cellular immunotherapies used for the treatment of some malignancies. This adoptive cell therapy represents a new paradigm in cancer treatment, one in which the patient’s own immune system, specifically T-cells, are engineered to treat his or her cancer. CAR T-cell therapy is a complex treatment associated with unique and serious toxicities, making education a necessity for both the patient and the health care provider. This presentation will provide an overview of CAR T-cell therapy, toxicity assessment and management strategies, administration considerations, and patient education needs for the health care provider.  

    Learning Outcomes: At the conclusion of this presentation, learners will be able to:
    • Describe the mechanism of action for CAR T-cells
    • Identify 3 common toxicities associated with CAR T-cells, as well as associated management strategies 
    • Verbalize administration considerations for CAR T-cell products

    Karen Anderson, MN, RN, AOCNS, BMTCN, CRNI®

    Infusion Manager

    Karen Anderson, MN, RN, AOCNS, BMTCN, CRNI®, is an infusion manager at the Banner University of Arizona Cancer Center in Tucson, Arizona. Previously, she was the clinical operations manager at the Bezos Family Immunotherapy Clinic at the Seattle Cancer Care Alliance, a clinic dedicated to supporting scientific advances in cellular immunotherapies and affiliated with the Fred Hutchison Cancer Research Center and the University of Washington. Her professional background includes roles in inpatient and ambulatory settings as a staff nurse, research nurse, and an oncology clinical nurse specialist. Ms. Anderson is currently a PhD student in nursing at the University of Arizona. 

    Disclosure: Kite Pharma- A Gilead Company; Consultant Fee; COI resolved

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 14, 2021

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.



    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.



  • The Normalization of Deviance in Health Care Delivery: Insights on Prevention, Learning, and Corrective Action From Organizational Science

    Contains 3 Component(s), 1.00 credit offered Recorded On: 10/17/2018

    In today’s health care climate, normalized deviation from established standards of practice is the focus of considerable research and practical intervention. It is now widely recognized that medical errors, workarounds, and adverse drug events are often caused by cultural norms and institutionalized patterns of behavior developed over time. Yet despite this recognition, most organizations encounter significant barriers to changing these normative pressures. In this webinar, change management tools and principles from the organizational sciences will be provided to help participants prevent, minimize, and correct the negative consequences of normative deviance. 

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Diagnose problems associated with normative deviance.
    • Gain exposure to contemporary change-management models.
    • Understand basic intervention strategies for overcoming dysfunctional deviance.

    In today’s health care climate, normalized deviation from established standards of practice is the focus of considerable research and practical intervention. It is now widely recognized that medical errors, workarounds, and adverse drug events are often caused by cultural norms and institutionalized patterns of behavior developed over time. Yet despite this recognition, most organizations encounter significant barriers to changing these normative pressures. In this webinar, change management tools and principles from the organizational sciences will be provided to help participants prevent, minimize, and correct the negative consequences of normative deviance. 

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Diagnose problems associated with normative deviance.
    • Gain exposure to contemporary change-management models.
    • Understand basic intervention strategies for overcoming dysfunctional deviance.

    Benjamin Dunford, PhD, MS, BS

    Associate Professor

    Benjamin Dunford, PhD, MS, BS, is an associate professor at the Krannert School of Management of Purdue University. He also has formal academic affiliations with Purdue’s department of psychological sciences and Regenstrief Center for Healthcare Engineering, and with the school of management at Seoul National University in South Korea. Professor Dunford is a recognized teacher at the master’s and executive levels on topics that include negotiation, organizational change, leadership, employee engagement, and conflict management. His research, which has been recognized for excellence, focuses on how management of people has an impact on organizational effectiveness, employee engagement, and safety outcomes, with a special emphasis on the health care industry. The author of more than 25 published peer reviewed journal articles, conference proceedings, and book chapters, Professor Dunford has consulted with numerous firms from a variety of industries, but most extensively in health care. 

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 17, 2021

  • Demystifying Gout: Pathogenesis and Guidelines for the Management of Gout

    Contains 3 Component(s), 1.00 credit offered Recorded On: 09/19/2018

    Gout is a chronic metabolic disease experienced by approximately 4% of the population of the United States. Gout is caused by the buildup of uric acid crystals in the joints, kidneys, and other body systems, and can be debilitating for patients. Early detection of gout results in significantly fewer complications over time and reduces associated comorbidities. This presentation is designed to discuss the clinical signs and symptoms of gout, identify the triggers associated with attacks of gout, examine various treatment options, and review common complications experienced by patients with gout. This session also will explore options aimed at reducing the incidence of attacks of gout, learning how to prevent complications, and understanding ways patients with gout can improve their quality of life.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Identify the signs and symptoms of gout.
    • Discuss the triggers and current treatments for gout.
    • Verbalize complications associated with chronic gout.

    Gout is a chronic metabolic disease experienced by approximately 4% of the population of the United States. Gout is caused by the buildup of uric acid crystals in the joints, kidneys, and other body systems, and can be debilitating for patients. Early detection of gout results in significantly fewer complications over time and reduces associated comorbidities. This presentation is designed to discuss the clinical signs and symptoms of gout, identify the triggers associated with attacks of gout, examine various treatment options, and review common complications experienced by patients with gout. This session also will explore options aimed at reducing the incidence of attacks of gout, learning how to prevent complications, and understanding ways patients with gout can improve their quality of life.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Identify the signs and symptoms of gout.
    • Discuss the triggers and current treatments for gout.
    • Verbalize complications associated with chronic gout.

    Vickie Sayles, BSN, RN-BC, CRNI®

    Clinical Nurse Manager

    Vickie L. Sayles, BSN, RN-BC, CRNI®, is the clinical nurse manager for the department of rheumatic and immunologic diseases at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board-certified in ambulatory nursing, rheumatology nursing, and infusion nursing, and she currently serves as treasurer of the Rheumatology Nurse Society. A presenter at various conferences in the United States, Ms. Sayles has spoken on subjects such as infusion nursing, infusion medications, biologic drugs, and biosimilar drugs.

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 19, 2021

  • Unleashing the Immune System: Treatment and Adverse Event Management for the Immuno-Oncology Patient

    Contains 3 Component(s), 1.00 credit offered Recorded On: 08/22/2018

    This presentation will discuss the clinical indications, administration, and adverse-event implications of novel immuno-oncology agents. As these therapies have emerged, it is evident that the side-effect profile and management of these agents are vastly different from traditional chemotherapy. Immuno-oncology-specific education for health care workers and patients is critical to the safe delivery and implementation of high-quality care. Throughout this presentation, the background of employing the immune system to fight cancer, and using real-patient scenarios to demonstrate best practices for infusion clinicians in the care, quality, and education of the immuno-oncology patient will be explored.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:

    • Identify 3 signs and symptoms of an immune-mediated adverse event.
    • Discuss the importance of early identification and treatment of adverse events.
    • Verbalize 3 different methods of education for immuno-oncology patients.

    This presentation will discuss the clinical indications, administration, and adverse-event implications of novel immuno-oncology agents. As these therapies have emerged, it is evident that the side-effect profile and management of these agents are vastly different from traditional chemotherapy. Immuno-oncology-specific education for health care workers and patients is critical to the safe delivery and implementation of high-quality care. Throughout this presentation, the background of employing the immune system to fight cancer, and using real-patient scenarios to demonstrate best practices for infusion clinicians in the care, quality, and education of the immuno-oncology patient will be explored.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:

    • Identify 3 signs and symptoms of an immune-mediated adverse event.
    • Discuss the importance of early identification and treatment of adverse events.
    • Verbalize 3 different methods of education for immuno-oncology patients.

    ​Megan Derr, MSN, RN, CMSRN, AONCS®

    Megan Derr, MSN, RN, CMSRN, AONCS®, is an oncology quality and evidence-based practice specialist at the Lehigh Valley Cancer Institute in Allentown, Pennsylvania. She is certified by the Oncology Nursing Certification Corporation as an advanced oncology clinical nurse specialist. A highlight in her current role has been educating the cancer institute about immuno-oncology agents, their side effects, and adverse event management. 

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 22, 2021